This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Dec;8(12):1082-3.

doi: 10.1016/S1474-4422(09)70298-4.

Alzheimer's disease: a global challenge for the 21st century

Jean François Dartigues

PMID: 19909903
DOI: 10.1016/S1474-4422(09)70298-4

Alzheimer's disease: a global challenge for the 21st century

Jean François Dartigues. Lancet Neurol. 2009 Dec.

. 2009 Dec;8(12):1082-3.

doi: 10.1016/S1474-4422(09)70298-4.

Author

Jean François Dartigues

PMID: 19909903
DOI: 10.1016/S1474-4422(09)70298-4

No abstract available

PubMed Disclaimer

Similar articles

Alzheimer's disease: clinical features and pharmacologic management.
Franks AS, Rawls WN. Franks AS, et al. Am J Manag Care. 1998 Apr;4(4):595-604; quiz 606-7. Am J Manag Care. 1998. PMID: 10179918 No abstract available.
Alzheimer disease: progress or profit?
Mount C, Downton C. Mount C, et al. Nat Med. 2006 Jul;12(7):780-4. doi: 10.1038/nm0706-780. Nat Med. 2006. PMID: 16829947 No abstract available.
Assessing health economic outcome in Alzheimer's disease clinical trials.
Jonsson L. Jonsson L. J Nutr Health Aging. 2007 Jul-Aug;11(4):353-5. J Nutr Health Aging. 2007. PMID: 17653498 Review.
[Delaying Alzheimer dementia. Patient and family relieved--costs lowered].
[No authors listed] [No authors listed] MMW Fortschr Med. 2000 Aug 24;142(33-34):56-7. MMW Fortschr Med. 2000. PMID: 10998909 German. No abstract available.
Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S. Rice DP, et al. Am J Manag Care. 2001 Aug;7(8):809-18. Am J Manag Care. 2001. PMID: 11519239 Review.

See all similar articles

Cited by

The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.
Walker LC, Schelle J, Jucker M. Walker LC, et al. Cold Spring Harb Perspect Med. 2016 Jul 1;6(7):a024398. doi: 10.1101/cshperspect.a024398. Cold Spring Harb Perspect Med. 2016. PMID: 27270558 Free PMC article. Review.
A group study on the effects of a short multi-domain cognitive training in healthy elderly Italian people.
Tagliabue CF, Guzzetti S, Gualco G, Boccolieri G, Boccolieri A, Smith S, Daini R. Tagliabue CF, et al. BMC Geriatr. 2018 Dec 27;18(1):321. doi: 10.1186/s12877-018-1014-x. BMC Geriatr. 2018. PMID: 30587151 Free PMC article. Clinical Trial.
Melatonin: A potential nighttime guardian against Alzheimer's.
Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C. Zhang Z, et al. Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11. Mol Psychiatry. 2025. PMID: 39128995 Free PMC article. Review.
Kynurenines, neurodegeneration and Alzheimer's disease.
Kincses ZT, Toldi J, Vécsei L. Kincses ZT, et al. J Cell Mol Med. 2010 Aug;14(8):2045-54. doi: 10.1111/j.1582-4934.2010.01123.x. Epub 2010 Jul 12. J Cell Mol Med. 2010. PMID: 20629991 Free PMC article. Review.
Prion-like mechanisms in Alzheimer disease.
Walker LC. Walker LC. Handb Clin Neurol. 2018;153:303-319. doi: 10.1016/B978-0-444-63945-5.00016-7. Handb Clin Neurol. 2018. PMID: 29887142 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information